Likewise, LPS-functionalized NPs were used to specifically target reactive astrocytes for spinal cord injury model systems, although some neuronal uptake was observed as well
Effects of glutathione S -transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk
Li Q, Liao J, Chen W, Zhang K, Li H, Ma F
Injectable GHK-Cu is not an FDA-approved drug and is typically sold "for research purposes only." Does GHK-Cu timing affect results
For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection